Page last updated: 2024-11-04

sulpiride and Basilar Artery Insufficiency

sulpiride has been researched along with Basilar Artery Insufficiency in 2 studies

Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.

Research Excerpts

ExcerptRelevanceReference
"Vertebrobasilar insufficiency (VBI) is a clinical syndrome which includes different transient brain stem symptoms."2.65[Calcium blockers in the therapy of vertebrobasilar insufficiency. Results of animal experiments and clinical studies]. ( Hofferberth, B, 1984)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hofferberth, B2
Grotemeyer, KH1

Trials

2 trials available for sulpiride and Basilar Artery Insufficiency

ArticleYear
[Calcium blockers in the therapy of vertebrobasilar insufficiency. Results of animal experiments and clinical studies].
    Fortschritte der Medizin, 1984, Jul-26, Volume: 102, Issue:27-28

    Topics: Animals; Calcium Channel Blockers; Cerebrovascular Circulation; Cinnarizine; Clinical Trials as Topi

1984
[Flunarizine and sulpiride--a comparison of 2 common antivertigo drugs in vertebrobasilar-induced vertigo].
    Der Nervenarzt, 1985, Volume: 56, Issue:10

    Topics: Adult; Aged; Cinnarizine; Clinical Trials as Topic; Double-Blind Method; Electroencephalography; Ele

1985